MACHINE LEARNING AND DEEP LEARNING
The AI Platform
While our main interest is to market our cancer tests, we’re also developing a continuously evolving AI platform for omics data analysis. Using various grants, we are planning to add modules for prognosis, response to treatment, toxicogenomics, microbiomics and pharmacogenomics.
The AI Multi Cancer Test
Together with AIE and Oncopredict ™ we developed the best multi cancer early detection test.
Our groundbreaking solution enables non-invasive early diagnosis for 13 types of cancers, with > 99% accuracy. The test increases treatment efficiency, patient survival rate, and lowers the costs. It is based on a radically new vision, combining Biomedical Knowledge, Data Science, and advanced AI. It only needs a drop of blood, avoiding the fear, pain, and risks related to the surgical procedures, actually dominating the cancer diagnosis practice.